Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2022 | 1 |
2024 | 2 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
PARP14 Contributes to the Development of the Tumor-Associated Macrophage Phenotype.
Int J Mol Sci. 2024 Mar 22;25(7):3601. doi: 10.3390/ijms25073601.
Int J Mol Sci. 2024.
PMID: 38612413
Free PMC article.
The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.
Guti E, Regdon Z, Sturniolo I, Kiss A, Kovács K, Demény M, Szöőr Á, Vereb G, Szöllősi J, Hegedűs C, Polgár Z, Virág L.
Guti E, et al. Among authors: sturniolo i.
Cancer Immunol Immunother. 2022 Sep;71(9):2151-2168. doi: 10.1007/s00262-022-03146-z. Epub 2022 Jan 23.
Cancer Immunol Immunother. 2022.
PMID: 35066605
Free PMC article.
Item in Clipboard
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery.
Sturniolo I, Váróczy C, Bede ÁM, Hegedűs C, Demény MÁ, Virág L.
Sturniolo I, et al.
J Vis Exp. 2024 Apr 26;(206). doi: 10.3791/65922.
J Vis Exp. 2024.
PMID: 38738886
Item in Clipboard
Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer.
Kumar J, Murugaiah V, Sotiriadis G, Kaur A, Jeyaneethi J, Sturniolo I, Alhamlan FS, Chatterjee J, Hall M, Kishore U, Karteris E.
Kumar J, et al. Among authors: sturniolo i.
Front Oncol. 2019 Jul 9;9:542. doi: 10.3389/fonc.2019.00542. eCollection 2019.
Front Oncol. 2019.
PMID: 31338320
Free PMC article.
Item in Clipboard
Targeting Nuclear NAD+ Synthesis Inhibits DNA Repair, Impairs Metabolic Adaptation and Increases Chemosensitivity of U-2OS Osteosarcoma Cells.
Kiss A, Ráduly AP, Regdon Z, Polgár Z, Tarapcsák S, Sturniolo I, El-Hamoly T, Virág L, Hegedűs C.
Kiss A, et al. Among authors: sturniolo i.
Cancers (Basel). 2020 May 7;12(5):1180. doi: 10.3390/cancers12051180.
Cancers (Basel). 2020.
PMID: 32392755
Free PMC article.
Item in Clipboard
Cite
Cite